These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2706192)

  • 1. Treatment of quinine overdosage with repeated oral charcoal.
    Prescott LF; Hamilton AR; Heyworth R
    Br J Clin Pharmacol; 1989 Jan; 27(1):95-7. PubMed ID: 2706192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral activated charcoal on quinine elimination.
    Lockey D; Bateman DN
    Br J Clin Pharmacol; 1989 Jan; 27(1):92-4. PubMed ID: 2706191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal.
    Boldy DA; Vale JA; Prescott LF
    Q J Med; 1986 Nov; 61(235):997-1002. PubMed ID: 3659250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination.
    Bateman DN; Blain PG; Woodhouse KW; Rawlins MD; Dyson H; Heyworth R; Prescott LF; Proudfoot AT
    Q J Med; 1985 Feb; 54(214):125-31. PubMed ID: 3983356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral activated charcoal on the pharmacokinetics of quinidine and quinine administered intravenously to rabbits.
    Hasan MM; Hassan MA; Rawashdeh NM
    Pharmacol Toxicol; 1990 Jul; 67(1):73-6. PubMed ID: 2395819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of quinine-induced blindness.
    Guly U; Driscoll P
    Arch Emerg Med; 1992 Sep; 9(3):317-22. PubMed ID: 1449580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.
    J Toxicol Clin Toxicol; 1999; 37(6):731-51. PubMed ID: 10584586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death and blindness due to overdose of quinine.
    Dyson EH; Proudfoot AT; Prescott LF; Heyworth R
    Br Med J (Clin Res Ed); 1985 Jul; 291(6487):31-3. PubMed ID: 3926054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of quinine poisoning with charcoal haemoperfusion.
    Morgan MD; Rainford DJ; Pusey CD; Robins-Cherry AM; Henry JG
    Postgrad Med J; 1983 Jun; 59(692):365-7. PubMed ID: 6634542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adsorption of quinine and quinidine to activated charcoal with and without magnesium sulfate.
    Akintonwa A; Orisakwe OE
    Vet Hum Toxicol; 1990 Dec; 32(6):567-8. PubMed ID: 2264267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of repeated-dose activated charcoal on the pharmacokinetics of sodium valproate in healthy volunteers.
    al-Shareef A; Buss DC; Shetty HG; Ali N; Routledge PA
    Br J Clin Pharmacol; 1997 Jan; 43(1):109-11. PubMed ID: 9056061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular quinine toxicity treated with hyperbaric oxygen.
    Wolff RS; Wirtschafter D; Adkinson C
    Undersea Hyperb Med; 1997 Jun; 24(2):131-4. PubMed ID: 9171472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinine poisoning in children.
    Grattan-Smith TM; Gillis J; Kilham H
    Med J Aust; 1987 Jul; 147(2):93-5. PubMed ID: 3600458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans.
    Salako LA; Sowunmi A
    Eur J Clin Pharmacol; 1992; 42(2):171-4. PubMed ID: 1618248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between plasma and saliva quinine levels in humans.
    Babalola CP; Bolaji OO; Ogunbona FA; Dixon PA
    Ther Drug Monit; 1996 Feb; 18(1):30-3. PubMed ID: 8848817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of quinine in plasma after a single oral and intramuscular dose in healthy adult Africans.
    Sowunmi A
    East Afr Med J; 1996 Feb; 73(2):111-4. PubMed ID: 8756050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of oral quinine in African patients suffering from acute uncomplicated falciparum malaria.
    Sowunmi A
    East Afr Med J; 1996 Aug; 73(8):519-23. PubMed ID: 8898467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of oral contraceptive use on the pharmacokinetics of quinine.
    Wanwimolruk S; Kaewvichit S; Tanthayaphinant O; Suwannarach C; Oranratnachai A
    Br J Clin Pharmacol; 1991 Feb; 31(2):179-81. PubMed ID: 2049234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinchonism: two case reports and review of acute quinine toxicity and treatment.
    Wolf LR; Otten EJ; Spadafora MP
    J Emerg Med; 1992; 10(3):295-301. PubMed ID: 1624742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-dose activated charcoal: a review of relevant clinical studies.
    Bradberry SM; Vale JA
    J Toxicol Clin Toxicol; 1995; 33(5):407-16. PubMed ID: 7650765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.